.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
US Department of Justice
Dow
Teva
Deloitte
Farmers Insurance
McKinsey
Daiichi Sankyo
Medtronic

Generated: December 12, 2017

DrugPatentWatch Database Preview

Cefprozil - Generic Drug Details

« Back to Dashboard

What are the generic sources for cefprozil and what is the scope of cefprozil patent protection?

Cefprozil
is the generic ingredient in two branded drugs marketed by Apotex Inc, Aurobindo Pharma, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, Sandoz, Teva Pharms, Corden Pharma, Aurobindo Pharma Ltd, Teva, and Wockhardt, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for cefprozil. Nineteen suppliers are listed for this compound.

Pharmacology for cefprozil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LupinCEFPROZILcefprozilFOR SUSPENSION;ORAL065261-002Dec 19, 2005ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareCEFPROZILcefprozilTABLET;ORAL065267-001Dec 19, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Corden PharmaCEFZILcefprozilTABLET;ORAL050664-002Dec 23, 1991DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncCEFPROZILcefprozilFOR SUSPENSION;ORAL065351-002Feb 29, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozCEFPROZILcefprozilTABLET;ORAL065235-002Nov 14, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdCEFPROZILcefprozilFOR SUSPENSION;ORAL065202-001Jun 30, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozCEFPROZILcefprozilTABLET;ORAL065235-001Nov 14, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo PharmaCEFPROZILcefprozilFOR SUSPENSION;ORAL065381-001Jan 30, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaCEFPROZILcefprozilTABLET;ORAL065208-001Dec 6, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
WockhardtCEFPROZILcefprozilTABLET;ORAL065428-002Jun 14, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Cipla
Queensland Health
Federal Trade Commission
Chinese Patent Office
Colorcon
Fish and Richardson
Harvard Business School
Healthtrust
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot